Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline

Authors: De Vos, F. Y. F. L., van Laarhoven, H. W. M., Laven, J. S. E., Themmen, A. P. N., Beex, L. V. A. M., Sweep, C. G. J., Seynaeve, C., Jager, A.

Source: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 84(2):252-260

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN320383766&indx=1&recIds=ETOCRN320383766

Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

Authors: Schilder, C. M. T., Seynaeve, C., Linn, S. C., Boogerd, W., Beex, L. V. A. M., Gundy, C. M., Nortier, J. W. R, van de Velde, C. J. H., van Dam, F. S. A. M., Schagen, S. B.

Source: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 76(2):133-141

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN280428772&indx=1&recIds=ETOCRN280428772

The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent

Authors: Baak, J. P. A., van Diest, P. J., Voorhorst, F. J., van der Wall, E., Beex, L. V. A. M., Vermorken, J. B., Janssen, E. A. M., Gudlaugsson, E., other collaborators of the Multicenter Morphometric Mammary Carcinoma Pro

Source: EUROPEAN JOURNAL OF CANCER. 43(3):527-535

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN203597380&indx=1&recIds=ETOCRN203597380

Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study

Authors: Nieboer, P., Buijs, C., Rodenhuis, S., Seynaeve, C., Beex, L. V. A. M., van der Wall, E., Richel, D. J., Nooij, M. A., Voest, E. E., Hupperets, P.

Source: JOURNAL OF CLINICAL ONCOLOGY. 23(33):8296-8304

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN179457530&indx=1&recIds=ETOCRN179457530

Prospective Multicenter Validation of the Independent Prognostic Value of the Mitotic Activity Index in Lymph Node-Negative Breast Cancer Patients Younger Than 55 Years

Authors: Baak, J. P. A., van Diest, P. J., Voorhorst, F. J., van der Wall, E., Beex, L. V. A. M., Vermorken, J. B., Janssen, E. A. M.

Source: JOURNAL OF CLINICAL ONCOLOGY. 23(25):5993-6001

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN175127134&indx=1&recIds=ETOCRN175127134

Complex of Urokinase-Type Plasminogen Activator with Its Type 1 Inhibitor Predicts Poor Outcome in 576 Patients with Lymph Node-Negative Breast Carcinoma

Authors: Manders, P., Tjan-Heijnen, V. C. G., Span, P. N., Grebenchtchikov, N., Geurts-Moespot, A., van Tienoven, D. T. H., Beex, L. V. A. M., Sweep, F. C. G. J.

Source: CANCER -PHILADELPHIA THEN HOBOKEN-. 101(3):486-494

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN162288049&indx=1&recIds=ETOCRN162288049

Survivin Is an Independent Prognostic Marker for Risk Stratification of Breast Cancer Patients

Authors: Span, P. N., Sweep, F. C. G. J., Wiegerinck, E. T. G., Tjan-Heijnen, V. C. G., Manders, P., Beex, L. V. A. M., de Kok, J. B.

Source: CLINICAL CHEMISTRY -WASHINGTON-. 50(11):1986-1993

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN158560768&indx=1&recIds=ETOCRN158560768

Vascular endothelial growth factor levels do not predict efficacy of systemic adjuvant treatment as assessed in 1127 breast cancer patients

Authors: Manders, P., Beex, L. V. A. M., Tjan-Heijnen, V. C. G., Span, P. N., Sweep, C. G. J.

Source: INTERNATIONAL JOURNAL OF ONCOLOGY. 25(2):511-518

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN153120560&indx=1&recIds=ETOCRN153120560

Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success

Authors: Span, P. N., Lindberg, R. L. P., Manders, P., Tjan-Heijnen, V. C. G., Heuvel, J. J. T. M., Beex, L. V. A. M., Sweep, C. G. J.

Source: JOURNAL OF PATHOLOGY. 202(4):395-402

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN146881449&indx=1&recIds=ETOCRN146881449

The complex between urokinase-type plasminogen activator (uPA) and its type-I inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer

Authors: Manders, P., Tjan-Heijnen, V. C. G., Span, P. N., Grebenchtchikov, N., Geurts-Moespot, A. J., van Tienoven, D. T. H., Beex, L. V. A. M., Sweep, F. C. G. J.

Source: THROMBOSIS AND HAEMOSTASIS -STUTTGART-. 91(3):514-521

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN146146970&indx=1&recIds=ETOCRN146146970

Mammaglobin Is Associated With Low-Grade, Steroid Receptor-Positive Breast Tumors From Postmenopausal Patients, and Has Independent Prognostic Value for Relapse-Free Survival Time

Authors: Span, P. N., Waanders, E., Manders, P., Heuvel, J. J. T. M., Foekens, J. A., Watson, M. A., Beex, L. V. A. M., Sweep, F. C. G. J.

Source: JOURNAL OF CLINICAL ONCOLOGY. 22(4):691-698

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN145626697&indx=1&recIds=ETOCRN145626697

Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients

Authors: Ottevanger, P. B., De Mulder, P. H. M., Grol, R. P. T. M., van Lier, H., Beex, L. V. A. M.

Source: EUROPEAN JOURNAL OF CANCER. 40(2):198-204

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN144453303&indx=1&recIds=ETOCRN144453303

Predictive Impact of Urokinase-Type Plasminogen Activator: Plasminogen Activator Inhibitor Type-1 Complex on the Efficacy of Adjuvant Systemic Therapy in Primary Breast Cancer

Authors: Manders, P., Tjan-Heijnen, V. C. G., Span, P. N., Grebenchtchikov, N., Foekens, J. A., Beex, L. V. A. M., Sweep, C. G. J.

Source: CANCER RESEARCH. 64(2):659-664

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN144241251&indx=1&recIds=ETOCRN144241251

Vascular Endothelial Growth Factor Independently Predicts the Efficacy of Postoperative Radiotherapy in Node-Negative Breast Cancer Patients

Authors: Manders, P., Sweep, F. C. G. J., Tjan-Heijnen, V. C. G., Geurts-Moespot, A., van Tienoven, D. T. H., Foekens, J. A., Span, P. N., Bussink, J., Beex, L. V. A. M.

Source: CLINICAL CANCER RESEARCH. 9(17):6363-6370

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN143048401&indx=1&recIds=ETOCRN143048401

Vascular Endothelial Growth Factor Is Associated with the Efficacy of Endocrine Therapy in Patients with Advanced Breast Carcinoma

Authors: Manders, P., Beex, L. V. A. M., Tjan-Heijnen, V. C. G., Span, P. N., Sweep, C. G. J.

Source: CANCER -PHILADELPHIA THEN HOBOKEN-. 98(10):2125-2132

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN140232293&indx=1&recIds=ETOCRN140232293

De behandeling van ductaal carcinoma in situ (DCIS) van de mamma

Authors: Westenberg, A. H., Rutgers, E. J. T., Peterse, J. L., Hendriks, J. H. C. L., Beex, L. V. A. M., Van Tienhoven, G.

Source: NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE. 147(44):2157-2161

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN140067518&indx=1&recIds=ETOCRN140067518

Molecular Beacon Reverse Transcription-PCR of Human Chorionic Gonadotropin-beta-3, -5, and -8 mRNAs Has Prognostic Value in Breast Cancer

Authors: Span, P. N., Manders, P., Heuvel, J. J. T. M., Thomas, C. M. G., Bosch, R. R., Beex, L. V. A. M., Sweep, C. G. J.

Source: CLINICAL CHEMISTRY -WASHINGTON-. 49(7):1074-1080

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN133585680&indx=1&recIds=ETOCRN133585680

Matrix Metalloproteinase Inhibitor Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs: A Prognostic Marker for Good Clinical Outcome in Human Breast Carcinoma

Authors: Span, P. N., Sweep, C. G. J., Manders, P., Beex, L. V. A. M., Leppert, D., Lindberg, R. L. P.

Source: CANCER -PHILADELPHIA-. 97(11):2710-2715

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN131890450&indx=1&recIds=ETOCRN131890450

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists' preferences

Authors: Nooij, M. A., de Haes, J. C. J. M., Beex, L. V. A. M., Wildiers, J., Klijn, J., Becquart, D., Jassem, J., Engelsman, E., Duchateau, L., EORTC Breast Cancer Group

Source: EUROPEAN JOURNAL OF CANCER. 39(5):614-621

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN128927736&indx=1&recIds=ETOCRN128927736

Repeated mammographic screening reduces breast cancer mortality along the continuum of age

Authors: Broeders, M. J. M., Verbeek, A. L. M., Straatman, H., Peer, P. G. M., Jong, P. C. M. P.-d., Beex, L. V. A. M., Hendriks, J. H. C. L., Holland, R.

Source: JOURNAL OF MEDICAL SCREENING. 9(4):163-167

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN124932117&indx=1&recIds=ETOCRN124932117